Evidence map›Paper›PMID 42823907›Full record

ReviewClinical pharmacology and therapeutics2026

Toward the Use of Real-World Data for Regulatory and HTA Decision-Making: Experiences and Recommendations from Six EU-Funded Projects.

Martin Russek, Jonas Peltner, Kerstin Pfeifer, Theodoros N Arvanitis, Dirk De Valck, Sieta T de Vries, Michel Dumontier, Vera Ehrenstein, Omaima El Hakouni, Gregory Epiphaniou and 25 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical pharmacology and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Martin RussekResearch Division, Federal Institute for Drugs and Medical Devices, Bonn, Germany.ORCID https://orcid.org/0009-0007-9509-0342
Jonas PeltnerResearch Division, Federal Institute for Drugs and Medical Devices, Bonn, Germany.ORCID https://orcid.org/0000-0002-1682-7913
Kerstin PfeiferResearch Division, Federal Institute for Drugs and Medical Devices, Bonn, Germany.ORCID https://orcid.org/0009-0008-8799-5851
Theodoros N ArvanitisDepartment of Electronic, Electrical and Systems Engineering, School of Engineering, University of Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0001-5473-135X
Dirk De ValckEuropean Organisation for Professionals and People with ALS (EUpALS), Leuven, Belgium.ORCID https://orcid.org/0000-0001-7868-2820
Sieta T de VriesDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.ORCID https://orcid.org/0000-0001-6090-2434
Michel DumontierDepartment of Advanced Computing Sciences, Maastricht University, Maastricht, the Netherlands.
Vera EhrensteinDepartment of Clinical Epidemiology and Center for Population Medicine, Aarhus University, Aarhus N, Denmark.ORCID https://orcid.org/0000-0002-3415-3254
Omaima El HakouniDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0009-0009-1616-6711
Gregory EpiphaniouWMG, University of Warwick, Coventry, UK.ORCID https://orcid.org/0000-0003-1054-6368
Gokhan ErtaylanEnvironmental Intelligence, VITO (Flemish Institute for Technological Research), Mol, Belgium.ORCID https://orcid.org/0000-0001-5602-6435
Joana FernandesINFARMED, National Authority of Medicines and Health Products, I.P, Information and Strategic Planning Department (DIPE), Lisbon, Portugal.ORCID https://orcid.org/0000-0002-4759-3996
Scott HansenThe Open Group, Berkshire, UK.
Stuart HarrisonETHOS Digital Health Ltd, Exeter, UK.ORCID https://orcid.org/0000-0003-3873-4512
Erzsébet Horváth-PuhóDepartment of Clinical Epidemiology and Center for Population Medicine, Aarhus University, Aarhus N, Denmark.ORCID https://orcid.org/0000-0002-3594-2212
Saif Ul IslamWMG, University of Warwick, Coventry, UK.ORCID https://orcid.org/0000-0002-9546-4195
Pekka KahriHUS Helsinki University Hospital, Helsinki, Finland.
Julia K MaderDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID https://orcid.org/0000-0001-7854-4233
Carsten MapleWMG, University of Warwick, Coventry, UK.ORCID https://orcid.org/0000-0002-4715-212X
Nikolaos MatragkasCEA, List, Université Paris-Saclay, Palaiseau, France.ORCID https://orcid.org/0000-0002-8594-1912
Shivani MisraDepartment of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-2886-0726
Peter G M MolDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.ORCID https://orcid.org/0000-0002-4262-3180
Anne PaakinahoSchool of Pharmacy, University of Eastern Finland, Kuopio Eastern Finland, Finland.ORCID https://orcid.org/0000-0003-0313-7080
Sami PakarinenHUS Helsinki University Hospital, Helsinki, Finland.
Martina RadanovićRISE - Research and Innovation Services, Göteborg, Sweden.ORCID https://orcid.org/0009-0002-6402-4856
Evy ReviersEuropean Organisation for Professionals and People with ALS (EUpALS), Leuven, Belgium.ORCID https://orcid.org/0000-0002-6044-5234
Kathrine Kold SørensenSteno Diabetes Center Copenhagen, Herlev, Denmark.ORCID https://orcid.org/0000-0002-9402-1317
Marco SpruitLeiden University Medical Center, Leiden, South-Holland, the Netherlands.ORCID https://orcid.org/0000-0002-9237-221X
Christina TikkaSchool of Pharmacy, University of Eastern Finland, Kuopio Eastern Finland, Finland.ORCID https://orcid.org/0000-0003-2078-8715
Anna-Maija TolppanenSchool of Pharmacy, University of Eastern Finland, Kuopio Eastern Finland, Finland.ORCID https://orcid.org/0000-0001-9270-9268
Christian Torp-PedersenSteno Diabetes Center Copenhagen, Herlev, Denmark.ORCID https://orcid.org/0000-0003-2892-6131
Mirna VelaRISE - Research and Innovation Services, Göteborg, Sweden.
Thuan VoSchool of Pharmacy, University of Eastern Finland, Kuopio Eastern Finland, Finland.ORCID https://orcid.org/0000-0002-8551-4240
Puriya Daniel Würtz YazdanfardSteno Diabetes Center Copenhagen, Herlev, Denmark.ORCID https://orcid.org/0000-0003-3060-7439
Britta HaenischResearch Division, Federal Institute for Drugs and Medical Devices, Bonn, Germany.ORCID https://orcid.org/0000-0002-4828-6058

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Real-world data are increasingly important for regulatory and health technology assessment decision-making, yet their effective use across Europe remains limited by technical, methodological, regulatory, and societal challenges. Drawing on the experiences of six Horizon Europe projects in the MetReal cluster, this review summarizes common barriers and emerging solutions for the use of real-world data in regulatory decision-making. Key challenges include complex and lengthy data access procedures, fragmented governance frameworks, variable data quality and completeness, limited interoperability, methodological difficulties in analyzing heterogeneous datasets, and infrastructure constraints within secure data environments. The article highlights opportunities to address these barriers through improved metadata, harmonization, federated analytics, synthetic data sandboxes, sustainable funding, and stronger collaboration between researchers, regulators, health technology assessment bodies, data holders, and citizens. These recommendations aim to strengthen Europe's health data ecosystem and support more robust, efficient, and trusted evidence generation for public health and patient benefit.

Identifiers

PMID42823907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.